Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease

Clinical trial NCT00675090 · COMPLETED

Trial details

NCT number: NCT00675090
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2008-02-21
Primary completion: 2009-06-16
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.